The gray zone

Area of Science:

• Laboratory Medicine
• Clinical Pathology

Background:

• Laboratory results are expected to be definitive, yet often present as equivocal or indeterminate.
• Terms like equivocal (uncertain significance) and indeterminate (uncertain) highlight ambiguity in diagnostic reporting.

Purpose of the Study:

• To examine the root causes of the "gray zone" in laboratory interpretation.
• To illustrate how this ambiguity impacts clinical decision-making with examples.

Main Methods:

• Analysis of the definitions and implications of "equivocal" and "indeterminate" results.
• Review of clinical scenarios where laboratory data exhibits overlapping distributions.

Main Results:

• The "gray zone" arises from overlapping data distributions, contrasting with clinicians' desire for binary results.
• Ambiguous results, including those using jargon like ASCUS (atypical squamous cells of undetermined significance) or AGUS (atypical glandular cells of undetermined significance), create interpretive flexibility.

Conclusions:

• The "gray zone" is an inherent aspect of laboratory interpretation due to data characteristics.
• Understanding the origins of this ambiguity is crucial for both laboratorians and clinicians to navigate result interpretation effectively.